Citadel Advisors - METACRINE INC ownership

METACRINE INC's ticker is MTCR and the CUSIP is 59101E103. A total of 33 filers reported holding METACRINE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of METACRINE INC
ValueSharesWeighting
Q3 2022$66,000
+106.2%
136,606
+112.5%
0.00%
Q2 2022$32,000
-50.8%
64,300
-39.5%
0.00%
Q1 2022$65,000
+66.7%
106,344
+85.7%
0.00%
Q4 2021$39,000
-64.9%
57,272
+76.6%
0.00%
Q3 2021$111,000
+131.2%
32,429
+155.1%
0.00%
Q2 2021$48,000
-98.1%
12,710
-94.8%
0.00%
-100.0%
Q3 2020$2,494,000245,7600.00%
Other shareholders
METACRINE INC shareholders Q1 2022
NameSharesValueWeighting ↓
venBio Partners LLC 3,059,123$24,045,0002.12%
Prosight Management, LP 563,303$4,428,0002.05%
VR Adviser, LLC 693,673$5,452,0000.80%
NEA Management Company, LLC 3,062,977$24,075,0000.64%
APOGEM CAPITAL LLC 35,150$276,0000.18%
Artal Group S.A. 924,898$7,270,0000.16%
EcoR1 Capital, LLC 333,332$2,620,0000.14%
ArrowMark Colorado Holdings LLC 1,028,295$8,082,0000.06%
Vivo Capital, LLC 146,426$1,151,0000.05%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 277,469$2,181,0000.04%
View complete list of METACRINE INC shareholders